HPR138 Analysis of Health Technology Assessments of Lung Cancer Therapies in Germany in the Last Decade: Is There an Association Between Added Benefit Ratings and Negotiated Reimbursement Prices?
Abstract
Authors
N Picker S Müller T Wilke